RSS   Newsletter   Contact   Advertise with us
Post Online Media

Former senior executive at Johnson & Johnson, joins Variant board

VariantVariant Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that it has appointed Jules Musing, former senior executive at Johnson & Johnson, as a director of the board.
Article continues below

READ MORE SCOLR Pharma names Carl Johnson as chairman

Mr. Musing, in the course of his 36-year career, has been responsible for worldwide licensing and acquisition of pharmaceutical and biotechnology products, as well as creation of strategic alliances and partnerships on a global basis.

Mr. Musing has been President of Johnson & Johnson companies in the US and Europe, and he was on the Board of Johnson & Johnson companies in Germany, France, Italy, and the UK. Mr.

He has been a member of the Management Board of Ortho Biotech (a J&J Biotechnology Company) in the US and Europe, CEO and President of Ares Serono, Inc. in the US, and Executive Vice President with responsibilities for Ares Serono companies in North and Latin America.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy